Although Mounjaro and Zepbound have been headlining Lilly’s financial reports in recent years, the company’s roster of ...

Q4 2024 Earnings Call Transcript February 13, 2025 Alnylam Pharmaceuticals, Inc. misses on earnings expectations. Reported ...

The growing elderly population is more susceptible to type 2 diabetes fuels the need for SGLT2 inhibitors in Asia Pacific. • The market segmentation is primarily based on indication, drug, ...

So you would consider things like beta blockers or calcium channel blockers ... in those patients that have a weak pump. Okay. So the SGLT2 inhibitors are one of the four pillars that we consider ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

Older adults had a lower risk for major adverse CV events than younger adults with SGLT2 inhibitors. Perspective from Sara Cromer, MD SGLT2 inhibitors confer greater risk reductions for major ...

sodium-glucose transporter 2 (SGLT2) inhibitors — these reduce the amount of glucose reabsorbed by the kidneys, meaning that it is excreted in the urine. A meta-analysis, published in the ...

SGLT-2 inhibitors, compared with DPP-4 inhibitors, were associated with a lower risk for liver cirrhosis among patients with type 2 diabetes. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors ...